National Level Faculty Development Programme
On Impact Of Interdisciplinary Research In Drug Discovery And Development




20th to 24th July
Gurugram


School of Medical and Allied Sciences organized a five-day Online Faculty Development Programme from 20th to 24th July 2020.

Prof Saahil Arora and Prof Manoj Gadewar from SMAS were the conveners of the program. Dean, SMAS, Prof Nitin graced the event on all the days.

Professor Aditya Malik, Vice-Chancellor, KRMU was the chief guest. Sir, in his welcome speech congratulated the School of Medical and Allied Sciences for organizing the event. He emphasized on the relevance of interdisciplinary research in present times.

Dr. Arghya Sett, Post-Doctoral Research Fellow, University of Bordeaux France was the first speaker. He delivered his talk on “Aptamer a magic molecule for theranostic applications.” Dr Sett explained that aptamers are short segments of DNA, RNA, or peptide that binds to a specific molecular target such as a protein. Biotechnology research is off late focusing on the unique characteristics of aptamers and is exploring their usage in the identification of new targets, as direct therapeutics, conjugates for targeted drug delivery, and agents for enhanced detection and monitoring. Aptamers are creating new possibilities in drug development.

Mr. Pramod Kumar, Drug Inspector, Central Drug Standard Control Organization addressed the participants on the topic “Overview and way of implementation of medical devices rules 2017 in India”. He shared that the Indian law regulating the quality and safety of medical devices has been amended and is now applicable to all medical devices, effective from April 1, 2020. Mr Pramod also shared the list of 37 categories of regulated medical devices.

Mr Manish Kumar, Drug Inspector, CDSCO, Ministry of Health & Family Welfare, Government of India, apprised the audience about the “New Drug and clinical trial rules 2019.”

Dr Suradip Das, is currently a postdoctoral fellow at the Department of Neurosurgery, University of Pennsylvania. His research involves, “bio fabrication of innervated tissue engineered muscles and investigating the implications of reinnervation in augmenting functional neuromuscular regeneration following severe musculoskeletal trauma.” Dr Suradip in a simplistic manner explained the complications associated with nerve innervation in muscles and its regeneration.

Dr. Yogesh Kulkarni, Associate Prof, NMIMS University, Mumbai delivered his lecture on “New drug discovery process and prospects.” Dr Yogesh explained the newer technologies, which can be used to target medical products to specific sites within the body and to manipulate genetic material.

Dr. Abhinav Garg, Manager, Research & Development Arbro Pharmaceutical Pvt. Ltd discussed on the topic “NDE lipid system in liquid filled hard capsule: A case study for early pharma, food product market entry.” He threw light on the possibility of incorporating liquids in hard gelatin capsule shells. He emphasized on the importance of commercialization of potential research drug candidates.

Mr. Vinod Arora, Associate Director, Development Operations, Kinapse delivered a talk on “Medical Writing in Pharmaceutical/ Healthcare Industry.” He explained the complex processes of clinical trials and regulatory procedures that lead to market approval for launch of new drugs. He shared that after gaining experience; one can work as a freelancer medical writer as well.

Dr. Vandana Chaudhary, Post-Doctoral Fellow School of Pharmacy, The University of Queensland, Australia and Dr. Ved Parkash, Associate Scientist Global Research, Novo Nordisk A/S Copenhagen, Denmark shared their views on “Education: 4.0 and advanced research for commercialization”. Both the speakers emphasized on the paradigm shift that’s required in the field of education. They shared case studies and personal experiences to explain the utmost urgency of adopting the newer teaching methodologies. Education 4.0 may reduce the academia-industry gap by a considerable amount.

Ms. Swati Mukharjee, DGM, Formulation & Development, Kusum Healthcare Pvt. Ltd explained the “Role of research and development in life cycle of generic product worldwide.” Ms Swati shared a few tips and tricks to prolong the Life cycle of a product to sustain profits, the varied newer formulations that are entering pharmaceutical markets and also the ones that are anticipated in near future.

Mr. Jagdish Chander, DGM, Regulatory Affairs, Kusum Healthcare Pvt. Ltd threw light on the “Role of regulatory affairs in research and development and in life cycle of generic product worldwide.” The talk focused on the regulatory requirements and documentation needed at each step of pharmaceutical production, both for branded and generic products. Mr Jagdish explained with the aid practical examples and the real-life problems encountered by him as an expert.

The session ended with a question-answer round. Prof Nitin, Dean, SMAS concluded the 5-day FDP by presenting Vote of Thanks to all the panelists, conveners, faculty coordinators and the delegates who participated in the program.